Pulmonary Function Tests (PFT) assist medical professionals in identifying, quantifying and managing respiratory system performance issues. Obtaining accurate Diffusion Capacity (DLco) values is affected by many contributing factors, in which Hemoglobin is one such factor that has a significant influence on the DLco measurement. When DLco values are abnormal, it is imperative to know the levels of hemoglobin at the time of testing so an accurate interpretation of the DLco test results can be made.
In many pulmonary lab settings, immediate Hemoglobin measurements are generally inconvenient or impossible; resulting in the use of patients’ historic test results or no correction for Hemoglobin being made. The NBM 200 noninvasive Hemoglobin system provides a reliable measurement of Hemoglobin, allowing for convenient DLco adjustments at the time of patient care.
> download (pdf): NBM 200 Hemoglobin Measurement
The OrSense NBM 200 is a non-invasive device for the analysis of hemoglobin, pulse and SpO2, which is perfectly suited for use in the pulmonary lab. The NBM 200 is simple to operate and maintain. This non-invasive system requires no blood draw, sharps or disposables. The NBM 200 greatly improves patient comfort and staff safety, minimizing infection risks. Test results are immediate and can be manually entered into the MGC Diagnostics software.
NON-INVASIVE OPTICAL MEASUREMENT PLATFORM
OrSense's patented SpectOLight™ technology, known as Occlusion Spectroscopy, uses a non-invasive optical measurement platform combined with a finger attached ring-shaped sensor probe. The pressure applied by the sensor temporarily occludes the blood flow in the finger, creating new blood dynamics which generate a unique, strong optical signal, yielding a high signalto-noise ratio which is wholly blood specific. Analysis of the signal provides the sensitivity necessary to measure hemoglobin, pulse-rate, oximetry (even under severe low perfusion levels), and other analyte concentrations.